Gabelli & Co Investment Advisers’s Medicus Sciences Acquisition Corp. Unit MSACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-15,400
Closed -$152K 556
2021
Q1
$152K Buy
+15,400
New +$157K 0.02% 347

Other funds holding MSACU

Gabelli & Co Investment Advisers's MSACU Position: Q2 2021 in Review

Gabelli & Co Investment Advisers sold out of Medicus Sciences Acquisition Corp. Unit (MSACU) in Q2 2021, closing a stake of 15,400 shares — an estimated $152K sold.

Gabelli & Co Investment Advisers first reported a position in MSACU in Q1 2021 and held it in 1 quarter. The position peaked at $152K in Q1 2021. 1 fund tracked by Wall St. Rank holds MSACU as of Q2 2021.

  • Gabelli & Co Investment Advisers reported no remaining Medicus Sciences Acquisition Corp. Unit position as of Q2 2021 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 15,400 Medicus Sciences Acquisition Corp. Unit shares in Q2 2021, an estimated $152K.
  • Gabelli & Co Investment Advisers first reported a position in Medicus Sciences Acquisition Corp. Unit in Q1 2021 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Medicus Sciences Acquisition Corp. Unit position peaked at $152K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Unit as of Q2 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.